1. Home
  2. NRSN vs REED Comparison

NRSN vs REED Comparison

Compare NRSN & REED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

N/A

Current Price

$1.44

Market Cap

7.6M

Sector

Health Care

ML Signal

N/A

Logo Reed's Inc.

REED

Reed's Inc.

N/A

Current Price

$0.97

Market Cap

8.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NRSN
REED
Founded
2017
1987
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
8.8M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
NRSN
REED
Price
$1.44
$0.97
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $91.75
N/A
AVG Volume (30 Days)
36.8K
★ 2.7M
Earning Date
09-25-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $34,065,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$27.29
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.25
$0.33
52 Week High
$7.50
$5.97

Technical Indicators

Market Signals
Indicator
NRSN
REED
Relative Strength Index (RSI) 31.32 67.45
Support Level $0.61 $0.72
Resistance Level $7.50 $1.04
Average True Range (ATR) 0.33 0.19
MACD -0.10 0.06
Stochastic Oscillator 24.85 89.40

Price Performance

Historical Comparison
NRSN
REED

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About REED Reed's Inc.

Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands. The company's portfolio of handcrafted, all-natural beverages is sold in outlets nationwide, including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores, and on-premise locations, including bars and restaurants. The company operates in a single reportable segment, which consists of manufacturing carbonated beverages under Reed's and Virgil's brand names.

Share on Social Networks: